Associations of C-Reactive protein, granulocytes and granulocyte-to-lymphocyte ratio with mortality from breast cancer in non-institutionalized American women

PLoS ONE

Volumn 11, Issue 6, 2016, Pages

  Wulaningsih, Wahyu ^a,b   Holmberg, Lars ^a,c   Abeler Doner, Lucie ^a   Ng, Tony ^d,e   Rohrmann, Sabine ^f   Van Hemelrijck, Mieke ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GADJAH MADA UNIVERSITY   (Indonesia)

^c UPPSALA UNIVERSITY   (Sweden)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN;

ABSOLUTE GRANULOCYTE COUNT; ADULT; AMERICAN; ARTICLE; BLOOD CELL RATIO; BODY MASS; BREAST CANCER; CANCER MORTALITY; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GRANULOCYTE; GRANULOCYTE LYMPHOCYTE RATIO; HUMAN; INFLAMMATION; MENOPAUSE; OBESITY; RISK ASSESSMENT; WAIST CIRCUMFERENCE; AGED; BLOOD; BREAST TUMOR; COMPLICATION; IMMUNOLOGY; LYMPHOCYTE; MIDDLE AGED; MORTALITY; PROPORTIONAL HAZARDS MODEL;

ADIPOSITY; AGED; BODY MASS INDEX; BREAST NEOPLASMS; C-REACTIVE PROTEIN; FEMALE; GRANULOCYTES; HUMANS; INFLAMMATION; LYMPHOCYTES; MIDDLE AGED; OBESITY; PROPORTIONAL HAZARDS MODELS; WAIST CIRCUMFERENCE;

EID: 84975501063     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0157482     Document Type: Article

References (45)

1. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144: 646-674. doi: 10. 1016/j.cell.2011.02.013 PMID: 21376230
2. Frasor J, Weaver A, Pradhan M, Dai Y, Miller LD, Lin CY, et al. (2009) Positive cross-talk between estrogen receptor and NF-kappaB in breast cancer. Cancer Res 69: 8918-8925. doi: 10.1158/0008-5472.CAN-09-2608 PMID: 19920189
3. Eklund CM (2009) Proinflammatory cytokines in CRP baseline regulation. Adv Clin Chem 48: 111-136. PMID: 19803417
4. Han Y, Mao F, Wu Y, Fu X, Zhu X, Zhou S, et al. (2011) Prognostic role of C-reactive protein in breast cancer: a systematic review and meta-analysis. Int J Biol Markers 26: 209-215. doi: 10.5301/JBM. 2011.8872 PMID: 22139643
5. Hu Q, Gou Y, Sun C, Ding W, Xu K, Gu B, et al. (2014) The prognostic value of C-reactive protein in renal cell carcinoma: A systematic review and meta-analysis. Urol Oncol 32: 50 e51-58.
6. Chen M, Huang J, Zhu Z, Zhang J, Li K (2013) Systematic review and meta-analysis of tumor biomarkers in predicting prognosis in esophageal cancer. BMC Cancer 13: 539. doi: 10.1186/1471-2407-13-539 PMID: 24206575
7. Zhou B, Liu J, Wang ZM, Xi T (2012) C-reactive protein, interleukin 6 and lung cancer risk: a meta-analysis. PLoS One 7: e43075. doi: 10.1371/journal.pone.0043075 PMID: 22912790
8. Heikkila K, Harris R, Lowe G, Rumley A, Yarnell J, Gallacher J, et al. (2009) Associations of circulating C-reactive protein and interleukin-6 with cancer risk: findings from two prospective cohorts and a metaanalysis. Cancer Causes Control 20: 15-26. doi: 10.1007/s10552-008-9212-z PMID: 18704713
9. Guo YZ, Pan L, Du CJ, Ren DQ, Xie XM (2013) Association between C-reactive protein and risk of cancer: a meta-analysis of prospective cohort studies. Asian Pac J Cancer Prev 14: 243-248. PMID: 23534731
10. Choi J, Joseph L, Pilote L (2013) Obesity and C-reactive protein in various populations: a systematic review and meta-analysis. Obes Rev 14: 232-244. doi: 10.1111/obr.12003 PMID: 23171381
11. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371: 569-578. doi: 10.1016/S0140-6736(08)60269-X PMID: 18280327
12. Jenkins P, Freeman S (2009) Pretreatment haematological laboratory values predict for excessive myelosuppression in patients receiving adjuvant FEC chemotherapy for breast cancer. Ann Oncol 20: 34-40.
13. Gwilliam B, Keeley V, Todd C, Gittins M, Roberts C, Kelly L, et al. (2011) Development of prognosis in palliative care study (PiPS) predictor models to improve prognostication in advanced cancer: prospective cohort study. BMJ 343: d4920. doi: 10.1136/bmj.d4920 PMID: 21868477
14. Azab B, Bhatt VR, Phookan J, Murukutla S, Kohn N, Terjanian T, et al. (2012) Usefulness of the neutrophil-to-lymphocyte ratio in predicting short- and long-term mortality in breast cancer patients. Ann Surg Oncol 19: 217-224. doi: 10.1245/s10434-011-1814-0 PMID: 21638095
15. Noh H, Eomm M, Han A (2013) Usefulness of pretreatment neutrophil to lymphocyte ratio in predicting disease-specific survival in breast cancer patients. J Breast Cancer 16: 55-59. doi: 10.4048/jbc.2013. 16.1.55 PMID: 23593082
16. Handin RI, Lux SE, Stossel TP (2003) Blood. Principles and Practice of Hematology, 2nd edition. Philadelphia: Lippincott Williams & Wilkins.
17. National Center for Health Statistics (1994) Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94. Series 1: programs and collection procedures. Vital Health Stat 1: 1-407.
18. (2010) NHANES III Linked Mortality File: Detailed Notes for Selected Variables. National Center for Health Statistics.
19. Gunter EW, Lewis BG, Koncikowski SM (1996) Laboratory Procedures Used for the Third Health and Nutrition Examination Survey (NHANES III), 1988-1994. Atlanta, GA: U.S. Department of Health and Human Services.
20. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB (1999) Elevated C-reactive protein levels in overweight and obese adults. JAMA 282: 2131-2135. PMID: 10591334
21. OB R (2007) A Caution Regarding Rules of Thumb for Variance Inflation Factors. Quality & Quantity 41: 673-690.
22. Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357: 539-545. PMID: 11229684
23. Gajewski TF, Schreiber H, Fu YX (2013) Innate and adaptive immune cells in the tumor microenvironment. Nat Immunol 14: 1014-1022. doi: 10.1038/ni.2703 PMID: 24048123
24. Allavena P, Sica A, Vecchi A, Locati M, Sozzani S, Mantovani A (2000) The chemokine receptor switch paradigm and dendritic cell migration: its significance in tumor tissues. Immunol Rev 177: 141-149.PMID: 11138772
25. Soucek L, Lawlor ER, Soto D, Shchors K, Swigart LB, Evan GI (2007) Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors. Nat Med 13: 1211-1218. PMID: 17906636
26. Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, et al. (2004) Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 10: 942-949. PMID: 15322536
27. Marigo I, Dolcetti L, Serafini P, Zanovello P, Bronte V (2008) Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells. Immunol Rev 222: 162-179. doi: 10.1111/j.1600-065X.2008.00602.x PMID: 18364001
28. Bronte V, Chappell DB, Apolloni E, Cabrelle A, Wang M, Hwu P, et al. (1999) Unopposed production of granulocyte-macrophage colony-stimulating factor by tumors inhibits CD8+ T cell responses by dysregulating antigen-presenting cell maturation. J Immunol 162: 5728-5737. PMID: 10229805
29. Andre F, Dieci MV, Dubsky P, Sotiriou C, Curigliano G, Denkert C, et al. (2013) Molecular pathways: involvement of immune pathways in the therapeutic response and outcome in breast cancer. Clin Cancer Res 19: 28-33. doi: 10.1158/1078-0432.CCR-11-2701 PMID: 23258741
30. de la Cruz-Merino L, Barco-Sanchez A, Henao Carrasco F, Nogales Fernandez E, Vallejo Benitez A, Brugal Molina J, et al. (2013) New insights into the role of the immune microenvironment in breast carcinoma. Clin Dev Immunol 2013: 785317. doi: 10.1155/2013/785317 PMID: 23861693
31. Petrie HT, Klassen LW, Kay HD (1985) Inhibition of human cytotoxic T lymphocyte activity in vitro by autologous peripheral blood granulocytes. J Immunol 134: 230-234. PMID: 3871101
32. Saxena NK, Vertino PM, Anania FA, Sharma D (2007) Leptin-induced growth stimulation of breast cancer cells involves recruitment of histone acetyltransferases and mediator complex to CYCLIN D1 promoter via activation of Stat3. J Biol Chem 282: 13316-13325. PMID: 17344214
33. Xiong H, Du W, Sun TT, Lin YW, Wang JL, Hong J, et al. (2013) A positive feedback loop between STAT3 and Cyclooxygenase-2 gene may contribute to Helicobacter pylori-associated human gastric tumorigenesis. Int J Cancer.
34. Allin KH, Nordestgaard BG, Flyger H, Bojesen SE (2011) Elevated pre-treatment levels of plasma C-reactive protein are associated with poor prognosis after breast cancer: a cohort study. Breast Cancer Res 13: R55. doi: 10.1186/bcr2891 PMID: 21639875
35. Prizment AE, Folsom AR, Dreyfus J, Anderson KE, Visvanathan K, Joshu CE, et al. (2013) Plasma C-reactive protein, genetic risk score, and risk of common cancers in the Atherosclerosis Risk in Communities study. Cancer Causes Control 24: 2077-2087. doi: 10.1007/s10552-013-0285-y PMID: 24036889
36. Allin KH, Bojesen SE, Nordestgaard BG (2009) Baseline C-reactive protein is associated with incident cancer and survival in patients with cancer. J Clin Oncol 27: 2217-2224. doi: 10.1200/JCO.2008.19. 8440 PMID: 19289618
37. Wulaningsih W, Holmberg L, Garmo H, Malmstrom H, Lambe M, Hammar N, et al. (2015) Prediagnostic serum inflammatory markers in relation to breast cancer risk, severity at diagnosis and survival in breast cancer patients. Carcinogenesis 36: 1121-1128. doi: 10.1093/carcin/bgv096 PMID: 26130675
38. Dossus L, Jimenez-Corona A, Romieu I, Boutron-Ruault MC, Boutten A, Dupre T, et al. (2014) C-reactive protein and postmenopausal breast cancer risk: results from the E3N cohort study. Cancer Causes Control 25: 533-539. doi: 10.1007/s10552-014-0355-9 PMID: 24504436
39. (1994) American Society of Clinical Oncology. Recommendations for the use of hematopoietic colonystimulating factors: evidence-based, clinical practice guidelines. J Clin Oncol 12: 2471-2508. PMID: 7964965
40. Li MX, Liu XM, Zhang XF, Zhang JF, Wang WL, Zhu Y, et al. (2014) Prognostic role of neutrophil-to-lymphocyte ratio in colorectal cancer: A systematic review and meta-analysis. Int J Cancer 134: 2403-2413. doi: 10.1002/ijc.28536 PMID: 24122750
41. Shimazaki J, Goto Y, Nishida K, Tabuchi T, Motohashi G, Ubukata H, et al. (2013) In patients with colorectal cancer, preoperative serum interleukin-6 level and granulocyte/lymphocyte ratio are clinically relevant biomarkers of long-term cancer progression. Oncology 84: 356-361. doi: 10.1159/000350836 PMID: 23689116
42. Arendt LM, McCready J, Keller PJ, Baker DD, Naber SP, Seewaldt V, et al. (2013) Obesity promotes breast cancer by CCL2-mediated macrophage recruitment and angiogenesis. Cancer Res 73: 6080-6093. doi: 10.1158/0008-5472.CAN-13-0926 PMID: 23959857
43. Murray CJ, Lopez AD (2013) Measuring the global burden of disease. N Engl J Med 369: 448-457. doi: 10.1056/NEJMra1201534 PMID: 23902484
44. Rao SR, Schoenfeld DA (2007) Survival methods. Circulation 115: 109-113. PMID: 17200454
45. Crawford DC, Sanders CL, Qin X, Smith JD, Shephard C, Wong M, et al. (2006) Genetic variation is associated with C-reactive protein levels in the Third National Health and Nutrition Examination Survey. Circulation 114: 2458-2465. PMID: 17101857